MILATUCYN Trademark Information

Trademark by Immunomedics, Inc.

pharmaceutical preparations for the treatment of cancer, particularly monoclonal antibodies for treatment of hematological tumors and solid cancers, and pharmaceutical preparations for the treatment of inflammatory diseases, including autoimmune diseases, immune dysregulation and transplant-related diseases, particularly monoclonal antibodies for treatment of these diseases

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: 7/25/2011
First Use In Commerce: 7/25/2011
General Information
Word mark: MILATUCYN
Status/Status Date:
CONTINUED USE AND INCONTESTIBILITY ACCEPTED
2/1/2017
Serial Number: 85085616
Filing Date: 7/15/2010
Registration Number: 4039477
Registration Date: 10/11/2011
Goods and Services: pharmaceutical preparations for the treatment of cancer, particularly monoclonal antibodies for treatment of hematological tumors and solid cancers, and pharmaceutical preparations for the treatment of inflammatory diseases, including autoimmune diseases, immune dysregulation and transplant-related diseases, particularly monoclonal antibodies for treatment of these diseases
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 12/14/2010
Last Applicant/Owner:
Immunomedics, Inc.
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
CONTINUED USE AND INCONTESTIBILITY ACCEPTED
2/1/2017
Correspondent Search:
Cynthia Smuzynska is a correspondent of MILATUCYN trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on